What Is Urology? Research Areas, Funding, and Training

Urology is the branch of medicine and biomedical science that deals with surgical and medical diseases of the urinary system and of the male reproductive organs. It is both a clinical specialty, with urologists who operate as well as manage disease medically, and a research discipline spanning basic physiology, clinical trials, device development and health-services research. (The name comes from the Greek ouron, urine.) This guide explains what urology covers and how its subfields divide up, how it relates to nephrology, and then adds the research-administration layer generic overviews leave out: who funds urologic research, what professional bodies shape the field, how trials and device studies are typically structured, and what training looks like. It is educational, not medical advice.

What Is Urology?

The organs within urology’s scope are the kidneys, adrenal glands, ureters, urinary bladder and urethra, together with the male reproductive organs: the testes, prostate and penis. Urologists see patients of all ages and, although the specialty is often associated with men’s health, a large share of its work concerns conditions that affect women as well, such as urinary incontinence, recurrent urinary tract infections and pelvic floor disorders.

Because the specialty combines office-based medical management with operating-room work, its research questions are unusually varied:

• How do the lower urinary tract and pelvic organs function? Storage and emptying of urine depend on the bladder, urethra, sphincters and the nervous system that coordinates them. Physiology and neuro-urology are the basic-science foundation of many clinical questions.
• What goes wrong? The conditions that U.S. federal research programs highlight include urinary tract infections, kidney stones, urinary incontinence and benign prostatic hyperplasia (BPH), along with interstitial cystitis/bladder pain syndrome (IC/BPS) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).
• How do we measure symptoms? Many urologic conditions are defined by what patients feel rather than by a laboratory value, so validated symptom questionnaires and patient-reported outcomes are central research tools.
• Which interventions work? Drugs, behavioral therapy, minimally invasive procedures, open and robotic surgery, and implanted or single-use devices are all studied, often against one another.
• Who gets cancer and how should it be detected and treated? Cancers of the prostate, bladder, kidney and testis fall within urologic oncology.

Major Subfields of Urology

• Endourology and stone disease — minimally invasive access to the urinary tract and the prevention and treatment of kidney stones.
• Laparoscopic and robotic surgery — minimally invasive operations on the kidney, prostate, bladder and other organs. See What Is Surgery? for the wider surgical research landscape.
• Urologic oncology — prostate, bladder, kidney and testicular cancer, overlapping heavily with oncology.
• Neurourology — bladder and sexual dysfunction arising from neurologic disease or injury, a bridge to neurology.
• Pediatric urology — congenital anomalies of the urinary tract and childhood voiding disorders; see What Is Pediatrics?
• Andrology and sexual medicine — male reproductive health, fertility and sexual function.
• Reconstructive urology — repair of strictures, trauma and other damage to the urinary tract.
• Female pelvic medicine and urogynecology — incontinence and pelvic organ prolapse, shared in practice with gynecology.

The boundaries are fluid. In the United States, the American Board of Urology (ABU) currently offers subspecialty certification in two areas, pediatric urology and urogynecology and reconstructive pelvic surgery, so not every subfield above corresponds to a separately certified track.

Urology and Nephrology: Where the Line Falls

Urology and nephrology are neighbors that share an organ but not a toolkit. Nephrologists mainly manage medical kidney disease, such as chronic kidney disease, glomerular disease, electrolyte disorders and dialysis. Urologists are surgeons and medical specialists for the urinary tract and the male reproductive organs: stones, obstruction, bladder dysfunction, prostate disease and tumors. They overlap most visibly on kidney stones, where a nephrologist may focus on metabolic evaluation and prevention while a urologist performs stone removal. For the medical-kidney side of the boundary, including KDIGO classification of chronic kidney disease, kidney registries and kidney trial endpoints, read What Is Nephrology?.

For research administrators the practical point is that the two fields often share a funder (see below), share some cohorts and data resources, and sometimes share a single protocol, for example a stone-prevention trial with both medical and procedural arms. Routing, reviewer expertise and budget lines can differ even when the scientific question overlaps.

How Urology Relates to Neighboring Disciplines

Urology is a clinical branch of medicine rooted in anatomy and physiology; see the overview of the branches of science for the wider map. Its closest research neighbors are oncology (tumor biology and cancer trials), nephrology (above), surgery (technique and outcomes research), pharmacology (drugs for BPH, overactive bladder and infection; see What Is Pharmacology?), geriatrics, because many lower urinary tract conditions become more common with age (What Is Geriatrics?), and endocrinology for hormone-related conditions (What Is Endocrinology?). Epidemiology and biostatistics support the cohort and trial work (What Is Epidemiology?, What Is Biostatistics?).

How Urologic Research Is Funded

In the United States, the lead federal funder of urologic disease research is the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of NIH. Within NIDDK, kidney, urologic and hematologic research is administered through the Division of Kidney, Urologic, and Hematologic Diseases. NIDDK’s urologic diseases research pages identify the conditions listed above as priorities and describe an NIDDK-supported research network on lower urinary tract symptoms, the Lower Urinary Tract Symptoms Network (LURN), whose stated aim is the development and use of improved assessments of urinary symptoms. NIDDK also reports prevalence estimates for several conditions, for example an estimated 3.3 million women with IC/BPS and 1.6 million men with CP/CPPS, which funders and applicants often use to justify public-health significance.

Because urologic cancers are cancers, a great deal of urologic oncology research is funded instead through the National Cancer Institute and other cancer-focused sponsors, and device and procedure studies may also draw on industry sponsorship. Applicants therefore often have to decide which institute’s mission best fits the question, and a pre-submission conversation with a program officer is a normal step.

Funding mechanisms vary: investigator-initiated awards, and cooperative agreements such as the U01 that consortia often use, in which NIH staff take a substantive role. Early-career investigators commonly enter through mentored awards such as the K99/R00, and competitiveness varies by institute and year (see NIH paylines for FY2026). Professional societies and disease foundations also fund fellowships and pilot grants. Funding opportunities and priorities change, so always confirm current details with the funder. Data produced by NIH-funded studies is subject to NIH data-sharing policy; see the NIH Data Management and Sharing Plan guide.

Study Designs, Endpoints and Device Research

Several features make urologic studies distinctive from a protocol-review standpoint.

• Patient-reported outcomes. Symptoms such as urgency, nocturia, pelvic pain or incontinence episodes are usually captured through questionnaires and voiding diaries. Choice, validation and burden of the instrument are frequent review questions, and the effort to improve urinary symptom assessments is exactly what a network like LURN is organized around.
• Surgical and procedural trials. Comparing operations or devices raises issues that drug trials largely avoid: surgeon experience and learning curves, the difficulty or impossibility of blinding, and the choice of a sham or an active comparator. For design background see non-inferiority vs. superiority trial design.
• Composite and time-to-event outcomes. Cancer and stone studies may use recurrence, progression or event-free survival, sometimes combined; see the dictionary entry on composite endpoints.
• Device and technology studies. Endourology and robotic surgery depend on instruments, lasers, catheters, implants and software. Studies of regulated medical devices follow device-specific regulatory and safety-reporting requirements that differ from drug trials, and administrators should confirm the applicable pathway with the regulator and the institution’s sponsored-programs and compliance offices. Which pathway applies depends on the device and its intended use.
• Cohorts, registries and claims data. Population-level questions about incontinence, infections or cancer treatment patterns are commonly answered with registries, electronic health records and administrative data.
• Preclinical models. Animal models of bladder function, obstruction and infection, and cell and organoid models, are run under the same oversight as other vertebrate research (see the animal research ethics guide).

Professional Societies and Guidelines

The American Urological Association (AUA), founded in 1902, is the principal U.S. professional society for urologists and publishes The Journal of Urology. Its annual meeting is a major venue for new urologic research. The AUA also develops evidence-based clinical practice guidelines, organized into oncology topics (bladder, prostate, renal and testicular cancer) and non-oncology topics (incontinence, pediatric urology, sexual and reproductive health, stones and others). Recent titles on its guidelines page include the Medical Management of Kidney Stones guideline and the Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia guideline, and joint AUA/SUO guidelines (with the Society of Urologic Oncology) on early detection and on advanced prostate cancer. Guideline lists are revised over time, so check the AUA site for current versions rather than relying on a snapshot.

Internationally, the European Association of Urology (EAU) and the Société Internationale d’Urologie (SIU) are two other widely cited bodies. Principal journals include The Journal of Urology, European Urology, Urology and BJU International.

Career and Training Pathways

The clinical path runs through medical school and a urology residency. In the United States residency is generally reported as five to six years, with the option of further fellowship training in a subspecialty; confirm the exact current length and requirements with the American Board of Urology and ACGME. The ABU conducts a Qualifying Examination (Part 1) and a Certifying Examination (Part 2), and certification is maintained through its continuing certification program. Residency positions are competitive, and many academic urologists add dedicated research years.

The research path runs through graduate study in physiology, cell and molecular biology, bioengineering, epidemiology or health services research, typically a PhD followed by postdoctoral training. Physician-scientists commonly combine clinical training with mentored K awards as noted above. Bioengineers and materials scientists contribute heavily to device development.

A Brief History

Urology is among the older surgical specialties, because stones, urinary obstruction and bladder disease have long been recognized and treated. The modern specialty took shape as instruments for looking inside the urinary tract and operating through small openings were developed, a trajectory that continues today in endoscopic, laparoscopic and robotic surgery. Its main U.S. professional body, the AUA, dates to 1902. This page deliberately avoids assigning dates to individual inventions or firsts that were not confirmed against a primary source; consult a dedicated medical history for those.

What Research Administrators Should Watch For

• Institute fit and routing. Decide early whether a proposal belongs with NIDDK, NCI or another sponsor, and whether it is kidney-medical (nephrology), urologic or both.
• Sensitive populations and data. Studies touching sexual function, fertility, incontinence or pelvic pain involve highly personal information, so consent language, privacy protections and data-sharing plans deserve care.
• Surgical and device logistics. Budgets need operating-room time, device costs, surgeon training and long follow-up for recurrence or durability.
• Outcome instruments. Questionnaires may have licensing terms or fees; check before building them into a budget.

Frequently Asked Questions

What is urology in simple terms?

Urology is the medical and surgical specialty for the urinary tract (kidneys, ureters, bladder, urethra) and the male reproductive organs. As a research field it studies how these organs work, what goes wrong, and which treatments, procedures and devices help.

What is the difference between urology and nephrology?

Nephrologists mainly manage medical kidney disease and dialysis. Urologists treat the urinary tract and male reproductive organs surgically and medically, including stones, obstruction, prostate disease and urologic cancers. They overlap on conditions such as kidney stones. See What Is Nephrology?.

What do urologists study or treat?

Conditions commonly associated with urology include urinary tract infections, kidney stones, urinary incontinence, BPH, bladder pain syndromes, male sexual and reproductive health problems, and cancers of the prostate, bladder, kidney and testis. This list describes the field, not what any individual should do about a health concern; people with symptoms should consult a clinician.

Who funds urologic research?

In the US the lead federal funder of non-cancer urologic disease research is NIH’s NIDDK; urologic cancer research is often funded through the National Cancer Institute. Foundations, professional societies and industry also contribute.

What is the AUA?

The American Urological Association, founded in 1902, is the main US professional society for urologists. It publishes The Journal of Urology and develops clinical practice guidelines.

How long does it take to become a urologist?

In the United States, after medical school, urology residency is generally reported as five to six years, with optional fellowship training afterward. Confirm current requirements with the American Board of Urology.

Is a urologic oncologist a urologist or an oncologist?

Urologic oncology is a subfield of urology, usually practiced by urologists who focus on cancers of the urinary tract and male reproductive organs, working alongside medical and radiation oncologists. See What Is Oncology?.

Related Guides

This guide is part of a series on scientific disciplines from a research-administration perspective. See the overview of the branches of science, What Is Nephrology?, What Is Oncology?, What Is Surgery? and What Is Geriatrics?.